Abiopharma

Clinical trial NCT06216158: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07712874: start date: 2026-08-19 → 2026-08-20.

Clinical trial NCT07209267 updates: 1. start date: 2026-09-01 → 2026-10-01 2. intervention model: SEQUENTIAL → PARALLEL

Clinical trial NCT04910568 updates: 1. enrollment: 126 → 186 participants 2. enrollment type: ACTUAL → ESTIMATED

Clinical trial NCT06635447: enrollment: 258 → 293 participants.

Coppetti Caspar Felix 🟢 acquired 65.0K shares of On Holding AG (ONON) at $30.67 ($2.0M) Transaction Date: Aug 14, 2026 | Filing ID: 000006

Weidner Marissa 🟡 adjusted position in 3.3K shares of WEBSTER FINANCIAL CORP (WBS) at $79.07 Transaction Date: Aug 13, 2026 | Filing ID: 000006

Clinical trial NCT07133880 updates: 1. completion date: 2025-12-01 → 2026-12-01 2. primary completion date: 2025-12-01 → 2026-12-01

Clinical trial NCT07379684 updates: 1. start date: 2026-08-31 → 2026-09-30 2. collaborators added: Novo Nordisk Foundation 3. collaborators removed: Novo Nordisk Foundation (NNF23SA0088536)

Clinical trial NCT05487599 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2032-08-30 → 2031-08-30 3. primary completion date: 2032-08-30 → 2031-08-30 4. enrollment: 15 → 8 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07069712 updates: 1. completion date: 2028-09-06 → 2029-07-16 2. primary completion date: 2027-01-28 → 2027-11-03

Clinical trial NCT06577766 updates: 1. completion date: 2026-09-24 → 2027-10-11 2. primary completion date: 2026-09-24 → 2027-10-11

Clinical trial NCT07355803 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-10-28 → 2026-08-05 3. primary completion date: 2026-10-28 → 2026-08-05 4. enrollment: 107 → 22 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07290569: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07105059 updates: 1. allocation: NA → RANDOMIZED 2. intervention model: SINGLE_GROUP → SEQUENTIAL